Showing results (111-120 of 260) with videos related to

Sort By:
Pageof 26
Pharmaceutics|February 25, 2023
Fast and Simple Liquid Chromatography-Isotope Dilution Tandem Mass Spectrometry Method for Therapeutic Drug Monitoring of Dalbavancin in Long-Term Treatment of Subacute and/or Chronic InfectionsRossella Barone, Matteo Conti, Pier Giorgio Cojutti, et al.
International Journal of Antimicrobial Agents|October 6, 2021
Usefulness of therapeutic drug monitoring in estimating the duration of dalbavancin optimal target attainment in staphylococcal osteoarticular infections: a proof-of-conceptPier Giorgio Cojutti, Matteo Rinaldi, Milo Gatti, et al.
Antibiotics (Basel, Switzerland)|September 27, 2025
Rapid Emergence of Cefiderocol Resistance Associated with Mutation of EnvZ Gene in a VIM-Producing ST307 Klebsiella pneumoniae StrainSimone Ambretti, Benedetta Secci, Raul Cetatean, et al.
Antimicrobial Agents and Chemotherapy|August 25, 2010
Therapeutic drug monitoring of linezolid: a retrospective monocentric analysisFederico Pea, Mario Furlanut, Piergiorgio Cojutti, et al.
Antibiotics (Basel, Switzerland)|April 28, 2023
Impact of Inflammation on Voriconazole Exposure in Critically ill Patients Affected by Probable COVID-19-Associated Pulmonary AspergillosisMilo Gatti, Giacomo Fornaro, Zeno Pasquini, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|May 21, 2019
Treatment of Candida infections with fluconazole in adult liver transplant recipients: Is TDM-guided dosing adaptation helpful?Elda Righi, Alessia Carnelutti, Umberto Baccarani, et al.
International Journal of Antimicrobial Agents|March 24, 2006
The effect of multifactorial, multidisciplinary educational interventions on appropriate use of teicoplaninFederico Pea, Pierluigi Viale, Federica Pavan, et al.
Jac-Antimicrobial Resistance|May 7, 2025
Feasibility of 24 h continuous-infusion cefiderocol administered by elastomeric pump in attaining an aggressive PK/PD target in the treatment of NDM-producing Klebsiella pneumoniae otomastoiditisStella Babich, Pier Giorgio Cojutti, Milo Gatti, et al.
Antimicrobial Agents and Chemotherapy|October 16, 2023
Could an optimized joint pharmacokinetic/pharmacodynamic target attainment of continuous infusion ceftazidime-avibactam be a way to avoid the need for combo therapy in the targeted treatment of deep-seated DTR Gram-negative infections?Milo Gatti, Matteo Rinaldi, Cecilia Bonazzetti, et al.
Antimicrobial Agents and Chemotherapy|February 19, 2009
Prospectively validated dosing nomograms for maximizing the pharmacodynamics of vancomycin administered by continuous infusion in critically ill patientsFederico Pea, Mario Furlanut, Camilla Negri, et al.
Pageof 26